Literature DB >> 33482083

p53 is a central regulator driving neurodegeneration caused by C9orf72 poly(PR).

Maya Maor-Nof1, Zohar Shipony2, Rodrigo Lopez-Gonzalez3, Lisa Nakayama2, Yong-Jie Zhang4, Julien Couthouis2, Jacob A Blum2, Patricia A Castruita5, Gabriel R Linares6, Kai Ruan7, Gokul Ramaswami8, David J Simon9, Aviv Nof2, Manuel Santana6, Kyuho Han2, Nasa Sinnott-Armstrong2, Michael C Bassik2, Daniel H Geschwind8, Marc Tessier-Lavigne9, Laura D Attardi10, Thomas E Lloyd7, Justin K Ichida6, Fen-Biao Gao3, William J Greenleaf2, Jennifer S Yokoyama5, Leonard Petrucelli4, Aaron D Gitler11.   

Abstract

The most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) is a GGGGCC repeat expansion in the C9orf72 gene. We developed a platform to interrogate the chromatin accessibility landscape and transcriptional program within neurons during degeneration. We provide evidence that neurons expressing the dipeptide repeat protein poly(proline-arginine), translated from the C9orf72 repeat expansion, activate a highly specific transcriptional program, exemplified by a single transcription factor, p53. Ablating p53 in mice completely rescued neurons from degeneration and markedly increased survival in a C9orf72 mouse model. p53 reduction also rescued axonal degeneration caused by poly(glycine-arginine), increased survival of C9orf72 ALS/FTD-patient-induced pluripotent stem cell (iPSC)-derived motor neurons, and mitigated neurodegeneration in a C9orf72 fly model. We show that p53 activates a downstream transcriptional program, including Puma, which drives neurodegeneration. These data demonstrate a neurodegenerative mechanism dynamically regulated through transcription-factor-binding events and provide a framework to apply chromatin accessibility and transcription program profiles to neurodegeneration.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ATAC-seq; C9orf72; TDP-43; amyotrophic lateral sclerosis; axonal degeneration; neurodegeneration; p53; puma

Mesh:

Substances:

Year:  2021        PMID: 33482083      PMCID: PMC7886018          DOI: 10.1016/j.cell.2020.12.025

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   66.850


  124 in total

1.  Puma is an essential mediator of p53-dependent and -independent apoptotic pathways.

Authors:  John R Jeffers; Evan Parganas; Youngsoo Lee; Chunying Yang; JinLing Wang; Jennifer Brennan; Kirsteen H MacLean; Jiawen Han; Thomas Chittenden; James N Ihle; Peter J McKinnon; John L Cleveland; Gerard P Zambetti
Journal:  Cancer Cell       Date:  2003-10       Impact factor: 31.743

Review 2.  p53 at a glance.

Authors:  Colleen A Brady; Laura D Attardi
Journal:  J Cell Sci       Date:  2010-08-01       Impact factor: 5.285

3.  p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.

Authors:  Liz J Valente; Daniel H D Gray; Ewa M Michalak; Josefina Pinon-Hofbauer; Alex Egle; Clare L Scott; Ana Janic; Andreas Strasser
Journal:  Cell Rep       Date:  2013-05-09       Impact factor: 9.423

4.  p53 and Cell Cycle Proteins Participate in Spinal Motor Neuron Cell Death in ALS.

Authors:  Srikanth Ranganathan; Robert Bowser
Journal:  Open Pathol J       Date:  2010-01-01

5.  Activation of p53-dependent growth suppression in human cells by mutations in PTEN or PIK3CA.

Authors:  Jung-Sik Kim; Carolyn Lee; Challice L Bonifant; Habtom Ressom; Todd Waldman
Journal:  Mol Cell Biol       Date:  2006-10-23       Impact factor: 4.272

Review 6.  The p53 tumor suppressor gene: from molecular biology to clinical investigation.

Authors:  T Soussi
Journal:  Ann N Y Acad Sci       Date:  2000-06       Impact factor: 5.691

7.  Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease.

Authors:  S M de la Monte; Y K Sohn; J R Wands
Journal:  J Neurol Sci       Date:  1997-11-06       Impact factor: 3.181

8.  TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97.

Authors:  Gillian P Ritson; Sara K Custer; Brian D Freibaum; Jake B Guinto; Dyanna Geffel; Jennifer Moore; Waixing Tang; Matthew J Winton; Manuela Neumann; John Q Trojanowski; Virginia M-Y Lee; Mark S Forman; J Paul Taylor
Journal:  J Neurosci       Date:  2010-06-02       Impact factor: 6.167

9.  Optineurin suppression causes neuronal cell death via NF-κB pathway.

Authors:  Mayumi Akizuki; Hirofumi Yamashita; Kengo Uemura; Hirofumi Maruyama; Hideshi Kawakami; Hidefumi Ito; Ryosuke Takahashi
Journal:  J Neurochem       Date:  2013-06-17       Impact factor: 5.372

10.  A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.

Authors:  Alan E Renton; Elisa Majounie; Adrian Waite; Javier Simón-Sánchez; Sara Rollinson; J Raphael Gibbs; Jennifer C Schymick; Hannu Laaksovirta; John C van Swieten; Liisa Myllykangas; Hannu Kalimo; Anders Paetau; Yevgeniya Abramzon; Anne M Remes; Alice Kaganovich; Sonja W Scholz; Jamie Duckworth; Jinhui Ding; Daniel W Harmer; Dena G Hernandez; Janel O Johnson; Kin Mok; Mina Ryten; Danyah Trabzuni; Rita J Guerreiro; Richard W Orrell; James Neal; Alex Murray; Justin Pearson; Iris E Jansen; David Sondervan; Harro Seelaar; Derek Blake; Kate Young; Nicola Halliwell; Janis Bennion Callister; Greg Toulson; Anna Richardson; Alex Gerhard; Julie Snowden; David Mann; David Neary; Michael A Nalls; Terhi Peuralinna; Lilja Jansson; Veli-Matti Isoviita; Anna-Lotta Kaivorinne; Maarit Hölttä-Vuori; Elina Ikonen; Raimo Sulkava; Michael Benatar; Joanne Wuu; Adriano Chiò; Gabriella Restagno; Giuseppe Borghero; Mario Sabatelli; David Heckerman; Ekaterina Rogaeva; Lorne Zinman; Jeffrey D Rothstein; Michael Sendtner; Carsten Drepper; Evan E Eichler; Can Alkan; Ziedulla Abdullaev; Svetlana D Pack; Amalia Dutra; Evgenia Pak; John Hardy; Andrew Singleton; Nigel M Williams; Peter Heutink; Stuart Pickering-Brown; Huw R Morris; Pentti J Tienari; Bryan J Traynor
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

View more
  28 in total

Review 1.  Human stem cell models of neurodegeneration: From basic science of amyotrophic lateral sclerosis to clinical translation.

Authors:  Elisa Giacomelli; Björn F Vahsen; Elizabeth L Calder; Yinyan Xu; Jakub Scaber; Elizabeth Gray; Ruxandra Dafinca; Kevin Talbot; Lorenz Studer
Journal:  Cell Stem Cell       Date:  2022-01-06       Impact factor: 24.633

Review 2.  Adenosine deaminase, not immune to a mechanistic rethink in central nervous system disorders?

Authors:  Benjamin Hall; Jonathan G George; Scott P Allen
Journal:  Histol Histopathol       Date:  2021-12-09       Impact factor: 2.303

3.  Core transcription programs controlling injury-induced neurodegeneration of retinal ganglion cells.

Authors:  Feng Tian; Yuyan Cheng; Songlin Zhou; Qianbin Wang; Aboozar Monavarfeshani; Kun Gao; Weiqian Jiang; Riki Kawaguchi; Qing Wang; Mingjun Tang; Ryan Donahue; Huyan Meng; Yu Zhang; Anne Jacobi; Wenjun Yan; Jiani Yin; Xinyi Cai; Zhiyun Yang; Shane Hegarty; Joanna Stanicka; Phillip Dmitriev; Daniel Taub; Junjie Zhu; Clifford J Woolf; Joshua R Sanes; Daniel H Geschwind; Zhigang He
Journal:  Neuron       Date:  2022-06-28       Impact factor: 18.688

4.  C9orf72 functions in the nucleus to regulate DNA damage repair.

Authors:  Liying He; Jiaqi Liang; Chaonan Chen; Jijun Chen; Yihui Shen; Shuangshuang Sun; Lei Li
Journal:  Cell Death Differ       Date:  2022-10-11       Impact factor: 12.067

Review 5.  Polymerases and DNA Repair in Neurons: Implications in Neuronal Survival and Neurodegenerative Diseases.

Authors:  Xiaoling Li; Guanghui Cao; Xiaokang Liu; Tie-Shan Tang; Caixia Guo; Hongmei Liu
Journal:  Front Cell Neurosci       Date:  2022-06-30       Impact factor: 6.147

6.  An anterograde pathway for sensory axon degeneration gated by a cytoplasmic action of the transcriptional regulator P53.

Authors:  David J Simon; Deanna M Belsky; Margot E Bowen; Christine Y J Ohn; Melanie K O'Rourke; Rebecca Shen; Garam Kim; Jason Pitts; Laura D Attardi; Marc Tessier-Lavigne
Journal:  Dev Cell       Date:  2021-04-05       Impact factor: 13.417

Review 7.  DNA damage as a mechanism of neurodegeneration in ALS and a contributor to astrocyte toxicity.

Authors:  Jannigje Rachel Kok; Nelma M Palminha; Cleide Dos Santos Souza; Sherif F El-Khamisy; Laura Ferraiuolo
Journal:  Cell Mol Life Sci       Date:  2021-06-26       Impact factor: 9.261

8.  Synaptic disruption and CREB-regulated transcription are restored by K+ channel blockers in ALS.

Authors:  Alberto Catanese; Sandeep Rajkumar; Daniel Sommer; Dennis Freisem; Alexander Wirth; Amr Aly; David Massa-López; Andrea Olivieri; Federica Torelli; Valentin Ioannidis; Joanna Lipecka; Ida Chiara Guerrera; Daniel Zytnicki; Albert Ludolph; Edor Kabashi; Medhanie A Mulaw; Francesco Roselli; Tobias M Böckers
Journal:  EMBO Mol Med       Date:  2021-06-14       Impact factor: 12.137

9.  Pathogenic effect of TP73 Gene Variants in People With Amyotrophic Lateral Sclerosis.

Authors:  Kristi L Russell; Jonathan M Downie; Summer B Gibson; Spyridoula Tsetsou; Matthew D Keefe; Jerry A Duran; Karla P Figueroa; Mark B Bromberg; L Charles Murtaugh; Joshua L Bonkowsky; Stefan M Pulst; Lynn B Jorde
Journal:  Neurology       Date:  2021-06-16       Impact factor: 11.800

Review 10.  Higher-order organization of biomolecular condensates.

Authors:  Charlotte M Fare; Alexis Villani; Lauren E Drake; James Shorter
Journal:  Open Biol       Date:  2021-06-16       Impact factor: 6.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.